Gail Boxer Marcus, a director at $NTRA, sold 3,400 shares of the company on 06-10-2025 for an estimated $558,733. We received data on the trade from a recent SEC filing. This was a sale of approximately 35.0% of their shares of this class of stock. Following this trade, they now own 6,304 shares of this class of $NTRA stock.
$NTRA Insider Trading Activity
$NTRA insiders have traded $NTRA stock on the open market 225 times in the past 6 months. Of those trades, 0 have been purchases and 225 have been sales.
Here’s a breakdown of recent trading of $NTRA stock by insiders over the last 6 months:
- STEVEN LEONARD CHAPMAN (CEO AND PRESIDENT) has made 0 purchases and 28 sales selling 232,631 shares for an estimated $35,473,086.
- MATTHEW RABINOWITZ (EXECUTIVE CHAIRMAN) has made 0 purchases and 15 sales selling 218,848 shares for an estimated $35,325,747.
- MICHAEL BURKES BROPHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 32 sales selling 90,125 shares for an estimated $15,231,949.
- SOLOMON MOSHKEVICH (PRESIDENT, CLINICALDIAGNOSTICS) has made 0 purchases and 29 sales selling 52,650 shares for an estimated $8,372,908.
- DANIEL RABINOWITZ (SEC. AND CHIEF LEGAL OFFICER) has made 0 purchases and 13 sales selling 37,830 shares for an estimated $6,219,834.
- JONATHAN SHEENA has made 0 purchases and 77 sales selling 37,834 shares for an estimated $5,869,858.
- JOHN FESKO (PRESIDENT, CHIEF BUS. OFFICER) has made 0 purchases and 13 sales selling 29,437 shares for an estimated $4,821,095.
- GAIL BOXER MARCUS has made 0 purchases and 18 sales selling 16,000 shares for an estimated $2,418,067.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTRA Hedge Fund Activity
We have seen 345 institutional investors add shares of $NTRA stock to their portfolio, and 326 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,795,315 shares (+56.3%) to their portfolio in Q1 2025, for an estimated $536,695,494
- BLACKROCK, INC. added 1,260,125 shares (+13.7%) to their portfolio in Q1 2025, for an estimated $178,194,276
- KYNAM CAPITAL MANAGEMENT, LP removed 854,528 shares (-42.3%) from their portfolio in Q1 2025, for an estimated $120,838,804
- GOLDMAN SACHS GROUP INC removed 734,551 shares (-43.3%) from their portfolio in Q1 2025, for an estimated $103,872,856
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 732,156 shares (+140.4%) to their portfolio in Q1 2025, for an estimated $103,534,179
- CITADEL ADVISORS LLC added 691,990 shares (+48.4%) to their portfolio in Q1 2025, for an estimated $97,854,305
- JPMORGAN CHASE & CO added 660,538 shares (+9.9%) to their portfolio in Q1 2025, for an estimated $93,406,678
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NTRA Analyst Ratings
Wall Street analysts have issued reports on $NTRA in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 05/15/2025
- Bernstein issued a "Outperform" rating on 01/10/2025
To track analyst ratings and price targets for $NTRA, check out Quiver Quantitative's $NTRA forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
